Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Intergroupe Francophone De Cancerologie Thoracique

Clinical trials sponsored by Intergroupe Francophone De Cancerologie Thoracique, explained in plain language.

Trials to join now! 2 Not yet finished but already full! 1

New drug cocktail targets tough lung cancer mutation

Disease control Ongoing

This study tests a combination of two targeted drugs, encorafenib and binimetinib, in adults with a specific genetic mutation (BRAF V600E) in advanced non-small cell lung cancer that has spread. The goal is to see how well the drugs shrink tumors and delay cancer growth. About 11…

Phase: PHASE2 • Sponsor: Intergroupe Francophone de Cancerologie Thoracique • Aim: Disease control

Last updated May 01, 2026 15:58 UTC